trending Market Intelligence /marketintelligence/en/news-insights/trending/O4b-YPJ4XfVXev3T78khiw2 content esgSubNav
In This List

RJ Biotech fiscal Q2 profit climbs YOY


Next in Tech | Episode 119: Defeating Digital Deficiencies


Street Talk | Episode 112: Banks face Bob Ross effect, tougher exams but 'huge' M&A on horizon


Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows

Case Study

A PE Firm Assesses Entity Sustainability Performance to Help Enhance Valuations

RJ Biotech fiscal Q2 profit climbs YOY

RJ Biotech Ltd. said its normalized net income for the fiscal second quarter ended Sept. 30 was 2.10 Indian rupees per share, an increase from 6 paise per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 19.9 million rupees, a gain from 560,630 rupees in the year-earlier period.

The normalized profit margin rose to 17.8% from 1.2% in the year-earlier period.

Total revenue climbed year over year to 111.9 million rupees from 47.6 million rupees, and total operating expenses increased 89.1% from the prior-year period to 71.5 million rupees from 37.8 million rupees.

Reported net income rose year over year to 31.8 million rupees, or 3.36 rupees per share, from 897,000 rupees, or 9 paise per share.

As of Nov. 2, US$1 was equivalent to 65.58 Indian rupees.